Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance
Isolates (79 in total) of Clostridium difficile obtained over a 2 year period from 785 patients suspected of having C. difficile-associated diarrhoea (CDAD) and being hospitalized in the University Hospital in Warsaw were characterized by toxigenicity profile and PCR ribotyping. Furthermore, their susceptibility to clindamycin and erythromycin was determined. Among the 79 C. difficile isolates, 35 were classified as A+B+, 1 as A+B+CDT+, 36 as A−B+ and 7 as A−B−. A total of 21 different PCR ribotypes was detected. Two main A+B+ strains circulated in our hospital: ribotype 014 and ribotype 046. Unexpectedly, the predominant PCR ribotype was type 017, a known A−B+ strain, and this accounted for about 45·5 % of all isolates cultured from patients with CDAD. Isolates belonging to PCR ribotype 017 were found in cases from epidemics of antibiotic-associated diarrhoea in the internal and surgery units. High-level resistance (MIC⩾256 mg l−1) to clindamycin and erythromycin was found in 39 (49 %) of the C. difficile isolates. Interestingly, 34 (94 %) of macrolide-lincosamide-streptogramin B (MLSB) type resistance strains did not produce toxin A, but produced toxin B and were A−B+ ribotype 017. Thirty-seven of the high-level resistance strains harboured the erythromycin-resistance methylase gene (ermB). C. difficile isolates (2/29) that had high-level clindamycin and erythromycin resistance, and belonged to PCR ribotype 046, were ermB negative. These investigations revealed that the predominant C. difficile strain isolated from symptomatic patients hospitalized in University Hospital in Warsaw was MLSB-positive clindamycin/erythromycin-resistant PCR ribotype 017.
AckermannG.,
DegnerA.,
CohenS. H.,
SilvaJ.Jr,
RodloffA. C.2003; Prevalence and association of macrolide-lincosamide-streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile
. J Antimicrob Chemother 51:599–603[CrossRef]
AlfaM. J.,
KabaniA.,
LyerlyD. & 7 other authors; 2000; Characterization of a toxin A-negative, toxin-B positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile -associated diarrhea. J Clin Microbiol 38:2706–2714
BarbutF.,
LalandeV.,
BurghofferB.,
ThienH. V.,
GrimprelE.,
PetitJ. C.2002; Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40:2079–2083[CrossRef]
DelmeeM.,
AvesaniV.1988; Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin, and tetracycline among 308 isolates of Clostridium difficile
. J Antimicrob Chemother 22:325–331[CrossRef]
FarrowK. A.,
LyrasD.,
RoddJ. I.2000; The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm (B) genes. Antimicrob Agents Chemother 44:411–413[CrossRef]
FarrowK. A.,
LyrasD.,
RoddJ. I.2001; Genomic analysis of the erythromycin resistance element Tn 5398 from Clostridium difficile
. Microbiology 147:2717–2728
GerdingD. N.,
JohnsonS.2001; Clindamycin-resistant Clostridium difficile
. In Emerging Infections5 pp 111–120 Edited by
ScheldW. M.,
CraigW. A,
HughesJ. M.
Washington, DC: American Society for Microbiology;
JohnsonS.,
SamoreM. H.,
FarrowK. A. & 9 other authors; 1999; Epidemics of diarrhea caused by a clindamycin resistant strain of Clostridium difficile in four hospitals. N Engl J Med 341:1645–1651[CrossRef]
KatoH.,
KatoN.,
KatowS.,
MuegawaT.,
NakamuraS.,
LyerlyD.1999; Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 175:197–203[CrossRef]
KuijperE. J.,
de WeerdtJ.,
KatoH.,
KatoN.,
van DamA. P.,
van der VormE. R.,
WeelJ.,
van RheenenC.,
DankertJ.2001; Nosocomial outbreak of Clostridium difficile -associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20:528–534[CrossRef]
MullanyP.,
WilksM.,
TabaqchaliS.1995; Transfer of macrolide-lincosamide-streptogramin B (MLS) resistance in Clostridium difficile is linked to a gene homologous with toxin A and is mediated by a conjugative transposon, Tn 5398
. J Antimicrob Chemother 35:305–315[CrossRef]
O'NeillG. L.,
OgunsolaF. T.,
BrazierJ. S.,
DuerdenB. I.1996; Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile
. Anaerobe 2:205–209[CrossRef]
PituchH.,
Obuch-WoszczatyńskiP.,
van BelkumA.,
Meisel-MikołajczykF.,
ŁuczakM.2001; Clindamycin resistant toxin A negative/toxin B positive Clostridium difficile strains isolated from patients with antibiotic-associated-diarrhoea. Int J Antimicrob Agents 17:S163
PituchH.,
van den BraakN.,
van LeeuvenW.,
van BelkumA.,
MartirosianG.,
Obuch-WoszczatyńskiP.,
ŁuczakM.,
Meisel-MikołajczykF.2001; Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 7:442–446[CrossRef]
PituchH.,
van BelkumA.,
van den BraakN.,
Obuch-WoszczatyńskiP.,
VerbrughH.,
Meisel-MikołajczykF.,
ŁuczakM.2003; Recent emergence of an epidemic clindamycin-resistance clone of Clostridium difficile among Polish patients with C. difficile -associated diarrhea. J Clin Microbiol 41:4184–4187[CrossRef]
PituchH.,
KreftD.,
Obuch-WoszczatyńskiP.,
WultańskaD.,
Meisel-MikołajczykF.,
ŁuczakM.,
van BelkumA.2005; Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile -associated diarrhea. J Clin Microbiol 43:472–475[CrossRef]
RotimiV. O.,
JamalW. Y.,
MokaddasE. M.,
BrazierJ. S.,
JohnyM.,
DuerdenB. I.2003; Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J Med Microbiol 52:705–709[CrossRef]
SpigagliaP.,
MastrantonioP.2004; Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53:1129–1136[CrossRef]
StubbsS. L.,
BrazierJ. S.,
O'NeillG. L.,
DuerdenB. I.1999; PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463
Van den BergR. J.,
ClaasE. C. J.,
OyibD. H.,
KlaassenC. H. W.,
DijkshoornL.,
BrazierJ. S.,
KuijperE. J.2004; Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 42:1035–1041[CrossRef]
Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance